About Eywa Pharma
Eywa Pharma is a company based in Singapore (Singapore) founded in 2015 by Srinivasan Seshan and Jayakumar Ramamoorthy. Eywa Pharma has raised $30 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 24 employees as of April 05, 2024.
- Headquarter Singapore, Singapore
- Employees 24 as on 05 Apr, 2024
- Founders Srinivasan Seshan, Jayakumar Ramamoorthy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eywa Pharma Private Limited
- Date of Incorporation 27 Apr, 2015
- Jurisdiction Chinglepet, Tamil Nadu, India
-
Annual Revenue
$1.33 M (USD)-21.66as on Mar 31, 2023
-
Net Profit
-$388.95 K (USD)-3601.26as on Mar 31, 2023
-
EBITDA
-$507.76 K (USD)-580.27as on Mar 31, 2023
-
Total Equity Funding
$30 M (USD)
in 1 rounds
-
Latest Funding Round
$30 M (USD), Series C
Oct 19, 2016
-
Investors
Eight Roads Ventures
& 1 more
-
Employee Count
24
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Eywa Pharma
Eywa Pharma has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series C round of $30 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eywa Pharma
Eywa Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked |
Investor details for Eywa Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eywa Pharma
Investment portfolio details for Eywa Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eywa Pharma
Detailed financials for Eywa Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eywa Pharma Comparisons
Peer comparison for Eywa Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eywa Pharma
Detailed competitors of Eywa Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eywa Pharma
Complete news archive for Eywa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eywa Pharma
Eywa Pharma was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Eywa Pharma is headquartered in Singapore, Singapore.
Srinivasan Seshan is the current CEO of Eywa Pharma. They have also founded this company.
Eywa Pharma is a funded company, having raised a total of $30M across 1 funding round to date.
As of Apr 05, 2024, the latest employee count at Eywa Pharma is 24.
Annual revenue of Eywa Pharma is $1.33M as on Mar 31, 2023.
Eywa Pharma was established in 2015 in Singapore, where operations center on the pharmaceutical sector. Drugs are produced for various therapeutic areas, supporting healthcare needs across different medical fields. The company maintains its headquarters in Singapore, with activities encompassing drug manufacturing processes tailored to industry standards. No specific services beyond production are detailed in available records.
Eywa Pharma has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.